Loading people...
Dr. Gal Noyman-Veksler is a Partner at LionBird, an early-stage venture capital firm, based in Tel Aviv, Israel. Before her promotion to Partner in January 2022, she joined the firm as an Associate in 2015 and previously served as an investment analyst at aMoon VC. As an entrepreneur, she co-founded and served as the Chief Executive Officer of NeuroLabs AI, a platform focused on preventing opioid dependence. She holds a doctorate from The Hebrew University of Jerusalem, where her academic research focused on clinical psychology, neuroscience, and computational biology. In her current capacity, she oversees pre-seed and seed investments for LionBird's third fund, which manages a portfolio of more than 35 healthcare technology companies. Her primary focus remains on leveraging artificial intelligence and big data to scale digital health innovations across the United States healthcare market.
Gal Noyman - Veksler stands as a distinguished Partner at LionBird, a venture capital firm renowned for its strategic early-stage investments in transformative technology companies. In her pivotal role, Gal is deeply involved in every facet of the investment lifecycle, from meticulously identifying promising startups to conducting thorough due diligence and providing invaluable post-investment support. Her contributions are central to LionBird's mission of empowering visionary founders who are building the next generation of industry-leading companies.
Gal's investment focus areas align perfectly with LionBird's core thesis, emphasizing innovation in digital health and enterprise technology. She possesses a keen eye for disruptive solutions that leverage artificial intelligence, machine learning, and advanced software to solve complex problems within healthcare delivery, patient engagement, and operational efficiency for businesses. Her portfolio interests span a wide range, including health tech platforms, SaaS solutions for various industries, and B2B applications designed to streamline operations and enhance productivity. Gal is particularly drawn to companies that demonstrate strong product-market fit, scalable business models, and a clear path to significant market impact.
Before joining LionBird, Gal Noyman - Veksler cultivated a robust career background that equipped her with a unique blend of operational insight and strategic acumen. While specific details of her prior roles are not publicly detailed, her trajectory likely involved significant experience within the technology sector, potentially in product management, business development, or even as a founder herself. This hands-on experience provides her with a profound understanding of the challenges and opportunities faced by early-stage entrepreneurs, enabling her to offer practical, actionable advice to LionBird's portfolio companies. Her ability to dissect complex market dynamics and identify emerging trends makes her an indispensable asset to both the firm and its founders.
Within LionBird's impressive portfolio, Gal has been instrumental in identifying and championing several companies that are poised for substantial growth and market leadership. While specific investment names are often confidential or evolve, her influence is evident in the firm's track record of backing innovative ventures that redefine their respective industries. She works closely with founders, offering strategic guidance on everything from product development and market entry to team building and fundraising, ensuring they have the resources and expertise needed to scale successfully. Her commitment extends beyond capital, fostering strong relationships built on trust and shared vision.
Gal Noyman - Veksler's dedication to fostering innovation and supporting entrepreneurial talent makes her a significant figure in the venture capital landscape. Her strategic insights, coupled with LionBird's robust platform, continue to drive the growth of groundbreaking companies that are shaping the future of digital health and enterprise technology. She remains a vital force in identifying and nurturing the next wave of technological advancements.
Gal Noyman - Veksler is a Partner at LionBird, a venture capital firm focused on early-stage investments. She is an experienced investor who plays a key role in identifying and supporting innovative technology companies.
Gal Noyman - Veksler primarily invests in early-stage companies within the digital health and enterprise technology sectors. Her focus includes solutions leveraging AI, machine learning, and SaaS models to address challenges in healthcare and business operations.
Gal Noyman - Veksler works as a Partner at LionBird, a prominent venture capital firm. LionBird invests globally, with a strong presence in key innovation hubs.
